Exacerbation Risk Exists for Patients With All Levels of Asthma Control/Severity
In patients using as-needed short-acting beta2-agonists, how are exacerbations associated with asthma control, maintenance adherence, and disease severity?
Asthma Information Center
Use of Biologics Reduces Exacerbations, Emergency Visits in Pediatric Asthma
A real-world study assessed how pediatric patients with moderate to severe asthma responded to the use dupilumab, mepolizumab, and omalizumab.
Mepolizumab Shows Real-World Efficacy in Allergic and Non-Allergic Asthma
While mepolizumab has proven safe and effective for severe asthma, how has it performed in treating those with allergic vs non-allergic asthma?
Allergen Exposure, Other Factors Predict Limited Airflow in Pediatric Asthma
What are the most significant predictors of airflow limitation in children 5 to 18 years of age with severe asthma?
Safety of Lebrikizumab Similar to Placebo in Patients With Uncontrolled Asthma
Researchers analyzed pooled safety data from 3 clinical trials of lebrikizumab for uncontrolled asthma to determine the drug’s safety profile.
Uncontrolled Asthma in Hispanic/Latino Patients Improved With Tezepelumab
A post hoc analysis of the PATHWAY and NAVIGATOR trials assessed efficacy of tezepelumab in Hispanic/Latino patients with severe, uncontrolled asthma.
Maintenance and Reliever Digital System vs Standard Care Improves Asthma Control
Researchers evaluated asthma control in participants receiving maintenance and reliever digital system vs standard maintenance and reliever inhalers.
Number of Patient-Reported Severe Asthma Triggers Predicts Morbidity
Which is a better predictor of morbidity in patients with severe asthma, blood eosinophil count or the number of patient-reported asthma triggers?
Asthma Exacerbations and Systemic Corticosteroid Use Reduced With Dupilumab
Researchers compared asthma exacerbation and cotricosteroid prescription reduction patients with asthma treated with dupilumab vs omalizumab, benralizumab, or mepolizumab.
Caregiver Depression Linked to Child Asthma Outcomes
Reduction in caregiver depressive symptoms may have positive impact on child asthma outcomes, partially mediated by child depressive symptom severity.
Health Effects of Wildfires: Recent Research and What Clinicians Need to Know
In addition to worsening asthma, other respiratory disorders, and heart conditions, exposure to wildfire smoke can also compromise immunity in healthy individuals.
Vaccine-Associated Aluminum Linked to Persistent Asthma in Young Children
Positive association seen for children with and without eczema; CDC is not changing current vaccine recommendations.
Bronchial Thermoplasty for Severe Asthma: 5-Year Clinical Trial Outcomes
A clinical trial of bronchial thermoplasty for severe asthma assessed efficacy and safety outcomes up to 5 years post-treatment.
Dupilumab Plus House Dust Mite Sublingual Immunotherapy for Allergic Asthma
Can combining dupilumab with house dust mite sublingual immunotherapy effectively control asthma in patients with HDM-related asthma and allergic rhinitis?
Can App-Based Devices for Pressurized Metered-Dose Inhalers Improve Asthma Outcomes?
How effective are add-on devices for pressurized metered-dose inhalers in helping patients with asthma to avoid poor outcomes associated with incorrect inhaler use?
AAD Releases Guideline on Atopic Dermatitis Comorbidities
A new American Academy of Dermatology (AAD) guideline describes available evidence on comorbidities associated with atopic dermatitis in adults.
Treating Severe Eosinophilic Asthma: Mepolizumab vs Benralizumab
What is the difference in efficacy between mepolizumab and benralizumab, 2 biologics approved for the treatment of severe eosinophilic asthma?
How Does Omalizumab Affect Antitussive Use in Patients With Allergic Asthma?
Does omalizumab therapy for patients with moderate to severe allergic asthma affect these patients’ use of antitussives?
Hormone Levels and Asthma, Rhinitis, and Eczema
Important clinical considerations for clinicians treating asthma, rhinitis, and atopic dermatitis are presented.
Which Biologics Reduce Allergic Response, Airway Hyperresponsiveness in Asthma?
What biologic therapies effectively treat airway hyperresponsiveness in asthma, and what do these therapies show about the underlying biology of asthma?
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Asthma Information Center
Loading... 
Loading...